Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial

Burt, 2015, Diagnosis and assessment of NAFLD: definitions and histopathological classification, Semin Liver Dis, 35, 207, 10.1055/s-0035-1562942 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Eshraghian, 2017, High prevalence of non-alcoholic fatty liver disease in the middle east: lifestyle and dietary habits, Hepatology, 65, 1077, 10.1002/hep.28937 Feng, 2014, Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population, World J Gastroenterol, 20, 17932, 10.3748/wjg.v20.i47.17932 Carallo, 2009, Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO study, J Gastroenterol, 44, 1156, 10.1007/s00535-009-0125-8 Francque, 2016, Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications, J Hepatol, 65, 425, 10.1016/j.jhep.2016.04.005 Portillo-Sanchez, 2015, High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels, J Clin Endocrinol Metab, 100, 2231, 10.1210/jc.2015-1966 Eshraghian, 2013, Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors, Arch Iran Med, 16, 584 Eshraghian, 2014, Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review, World J Gastroenterol, 20, 8102, 10.3748/wjg.v20.i25.8102 Targher, 2015, Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?, J Endocrinol Invest, 38, 817, 10.1007/s40618-015-0315-6 Christakos, 2016, Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects, Physiol Rev, 96, 365, 10.1152/physrev.00014.2015 Ju, 2014, Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis, J Clin Endocrinol Metab, 99, 1053, 10.1210/jc.2013-3577 Gagnon, 2012, Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab), J Clin Endocrinol Metab, 97, 1953, 10.1210/jc.2011-3187 Pittas, 2010, Systematic review: vitamin D and cardiometabolic outcomes, Ann Intern Med, 152, 307, 10.7326/0003-4819-152-5-201003020-00009 George, 2012, Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta­analysis, Diabet Med, 29, e142, 10.1111/j.1464-5491.2012.03672.x Oosterwerff, 2014, Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial, Am J Clin Nutr, 100, 152, 10.3945/ajcn.113.069260 Dasarathy, 2014, Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease, Liver Int, 34, e118, 10.1111/liv.12312 Rhee, 2013, High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome, Endocr J, 60, 743, 10.1507/endocrj.EJ12-0387 Barchetta, 2011, Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes, BMC Med, 12, 85, 10.1186/1741-7015-9-85 Targher, 2007, Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease, Nutr Metab Cardiovasc Dis, 17, 517, 10.1016/j.numecd.2006.04.002 Eshraghian, 2017, Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density, Minerva Endocrinol, 42, 164, 10.23736/S0391-1977.16.02587-6 Eliades, 2013, Meta-analysis: vitamin D and non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 38, 246, 10.1111/apt.12377 Bozic, 2016, Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis, J Hepatol, 65, 748, 10.1016/j.jhep.2016.05.031 Sharifi, 2014, Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial, Endocrine, 47, 70, 10.1007/s12020-014-0336-5 Foroughi, 2014, Effect of Vitamin D supplementation on C-reactive protein in patients with nonalcoholic fatty liver, Int J Prev Med, 5, 969 Papapostoli, 2016, Effect of short-term vitamin D correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP), J Gastrointest Liver Dis, 25, 175, 10.15403/jgld.2014.1121.252.cap Lorvand Amiri, 2016, Regression of non-alcoholic fatty liver by vitamin D supplement: a double-blind randomized controlled clinical trial, Arch Iran Med, 19, 631 Barchetta, 2016, No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial, BMC Med, 29, 92, 10.1186/s12916-016-0638-y Lips, 2006, Vitamin D physiology, Prog Biophys Mol Biol, 92, 4, 10.1016/j.pbiomolbio.2006.02.016 Barchetta, 2012, Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus, Hepatology, 56, 2180, 10.1002/hep.25930 Eftekhari, 2011, Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients, Asia Pac J Clin Nutr, 20, 521 Eftekhari, 2014, The effect of calcitriol on lipid profile and oxidative stress in hyperlipidemic patients with type 2 diabetes mellitus, ARYA Atheroscler, 10, 82